Steve Pedrini

4.5k total citations · 3 hit papers
43 papers, 2.8k citations indexed

About

Steve Pedrini is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Steve Pedrini has authored 43 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Physiology, 14 papers in Molecular Biology and 10 papers in Psychiatry and Mental health. Recurrent topics in Steve Pedrini's work include Alzheimer's disease research and treatments (30 papers), Dementia and Cognitive Impairment Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Steve Pedrini is often cited by papers focused on Alzheimer's disease research and treatments (30 papers), Dementia and Cognitive Impairment Research (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). Steve Pedrini collaborates with scholars based in United States, Australia and United Kingdom. Steve Pedrini's co-authors include Federico Licastro, Sam Gandy, Ralph N. Martins, Cinzia Ferri, Valeria M. Casadei, Luigi Grimaldi, Pratishtha Chatterjee, Hamid R. Sohrabi, Lizabeth Jane Davis and Giorgio Annoni and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Steve Pedrini

43 papers receiving 2.8k citations

Hit Papers

Neuronal SIRT1 Activation as a Novel Mechanism Underlying... 2006 2026 2012 2019 2006 2021 2022 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Neuronal SIRT1 Activation as a Novel Mechanism Underlying the Prevention of Alzheimer Disease Amyloid Neuropathology by Calorie Restriction
    2006 522 citations Steve Pedrini, Sam Gandy et al. profile →
  2. Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease
    2021 276 citations Pratishtha Chatterjee, Steve Pedrini et al. Translational Psychiatry profile →
  3. Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort
    2022 155 citations Pratishtha Chatterjee, Steve Pedrini et al. Alzheimer s & Dementia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steve Pedrini United States 24 1.6k 1.0k 523 471 334 43 2.8k
Jiong Shi United States 27 1.1k 0.7× 813 0.8× 492 0.9× 492 1.0× 217 0.6× 79 2.9k
Yu Yamazaki Japan 22 1.5k 1.0× 913 0.9× 828 1.6× 284 0.6× 311 0.9× 69 2.9k
Cyntia Tremblay Canada 27 1.5k 0.9× 748 0.7× 526 1.0× 132 0.3× 381 1.1× 57 2.6k
Thomas J. Montine United States 24 1.4k 0.9× 774 0.8× 449 0.9× 548 1.2× 537 1.6× 37 2.9k
Tim West United States 25 1.0k 0.6× 501 0.5× 230 0.4× 396 0.8× 179 0.5× 63 2.4k
Ester Verdaguer Spain 33 865 0.6× 1.4k 1.4× 417 0.8× 146 0.3× 230 0.7× 106 3.2k
Liying Han China 21 1.4k 0.9× 943 0.9× 587 1.1× 420 0.9× 256 0.8× 51 3.2k
Philip B. Verghese United States 22 2.0k 1.3× 1000 1.0× 806 1.5× 483 1.0× 338 1.0× 41 3.2k
Inês Baldeiras Portugal 26 1.1k 0.7× 835 0.8× 393 0.8× 447 0.9× 325 1.0× 102 2.4k

Countries citing papers authored by Steve Pedrini

Since Specialization
Citations

This map shows the geographic impact of Steve Pedrini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steve Pedrini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steve Pedrini more than expected).

Fields of papers citing papers by Steve Pedrini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steve Pedrini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steve Pedrini. The network helps show where Steve Pedrini may publish in the future.

Co-authorship network of co-authors of Steve Pedrini

This figure shows the co-authorship network connecting the top 25 collaborators of Steve Pedrini. A scholar is included among the top collaborators of Steve Pedrini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steve Pedrini. Steve Pedrini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eratne, Dhamidhu, Qiao-Xin Li, Courtney Lewis, et al.. (2024). Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort. Journal of Neurology. 272(1). 25–25. 4 indexed citations
2.
Sewell, Kelsey R., Stephanie R. Rainey‐Smith, Steve Pedrini, et al.. (2024). The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults. GeroScience. 46(6). 5911–5923. 11 indexed citations
3.
Pedrini, Steve, James D. Doecke, Eugene Hone, et al.. (2022). Plasma high‐density lipoprotein cargo is altered in Alzheimer's disease and is associated with regional brain volume. Journal of Neurochemistry. 163(1). 53–67. 13 indexed citations
4.
Chatterjee, Pratishtha, Steve Pedrini, Erik Stoops, et al.. (2021). Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer’s disease. Translational Psychiatry. 11(1). 27–27. 276 indexed citations breakdown →
5.
Chatterjee, Pratishtha, Maryam Mohammadi, Kathryn Goozee, et al.. (2020). Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load. Journal of Alzheimer s Disease. 76(1). 291–301. 7 indexed citations
6.
Pedrini, Steve, Eugene Hone, Veer Bala Gupta, et al.. (2020). Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer’s Disease Patients and Correlates with Cognitive Performance. Journal of Alzheimer s Disease. 77(2). 733–744. 10 indexed citations
7.
Chatterjee, Pratishtha, Cintia B. Dias, Tejal Shah, et al.. (2020). Potential of coconut oil and medium chain triglycerides in the prevention and treatment of Alzheimer’s disease. Mechanisms of Ageing and Development. 186. 111209–111209. 72 indexed citations
8.
Chatterjee, Pratishtha, Henrik Zetterberg, Kathryn Goozee, et al.. (2019). Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease. Journal of Neuroinflammation. 16(1). 186–186. 52 indexed citations
9.
Pedrini, Steve, Veer Bala Gupta, Eugene Hone, et al.. (2017). [P4–136]: IL‐10 AND IL‐12/23P40 ARE JOINTLY ASSOCIATED AS PREDICTORS OF Aβ‐AMYLOID LOAD IN A BROADER BLOOD‐BASED BIOMARKER PANEL. Alzheimer s & Dementia. 13(7S_Part_27). 1 indexed citations
10.
Gupta, Veer Bala, James D. Doecke, Eugene Hone, et al.. (2015). Plasma apolipoprotein J as a potential biomarker for Alzheimer's disease: Australian Imaging, Biomarkers and Lifestyle study of aging. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 3(1). 18–26. 30 indexed citations
11.
Gupta, Veer Bala, Andrea C. Wilson, Samantha C. Burnham, et al.. (2015). Follow-up plasma apolipoprotein E levels in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) cohort. Alzheimer s Research & Therapy. 7(1). 16–16. 17 indexed citations
12.
Pedrini, Steve, Hannah Brautigam, James Schmeidler, et al.. (2009). Dietary composition modulates brain mass and solubilizable Aβ levels in a mouse model of aggressive Alzheimer's amyloid pathology. Molecular Neurodegeneration. 4(1). 40–40. 39 indexed citations
13.
Pedrini, Steve, Alexey Bogush, & Michelle E. Ehrlich. (2008). Phosphatidylinositide 3‐kinase and protein kinase C zeta mediate retinoic acid induction of DARPP‐32 in medium size spiny neurons in vitro. Journal of Neurochemistry. 106(2). 917–924. 6 indexed citations
14.
15.
Carter, Troy L., Steve Pedrini, Jorge Ghiso, Michelle E. Ehrlich, & Sam Gandy. (2005). Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis. Neuroscience Letters. 392(3). 235–239. 23 indexed citations
16.
Morgan, Kevin, Federico Licastro, Louise Tilley, et al.. (2001). Polymorphism in the alpha1-antichymotrypsin (ACT) gene promoter: effect on expression in transfected glial and liver cell lines and plasma ACT concentrations. Human Genetics. 109(3). 303–310. 25 indexed citations
17.
Licastro, Federico, Eliezer Masliah, Steve Pedrini, & Leon J. Thal. (2000). Blood Levels of Alpha-1-Antichymotrypsin and Risk Factors for Alzheimer’s Disease: Effects of Gender and Apolipoprotein E Genotype. Dementia and Geriatric Cognitive Disorders. 11(1). 25–28. 136 indexed citations
18.
Licastro, Federico, Steve Pedrini, Ludovica Caputo, et al.. (2000). Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. Journal of Neuroimmunology. 103(1). 97–102. 339 indexed citations
19.
Licastro, Federico, Steve Pedrini, Marzia Govoni, et al.. (1999). Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Neuroscience Letters. 270(3). 129–132. 38 indexed citations
20.
Licastro, Federico, et al.. (1998). Prostaglandin E2 Induced Polymerization of Human α-1-Antichymotrypsin and Suppressed Its Protease Inhibitory Activity: Implications for Alzheimer's Disease. Biochemical and Biophysical Research Communications. 249(1). 182–186. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiong Shi Breakdown of academic impact, for papers by Yu Yamazaki Breakdown of academic impact, for papers by Cyntia Tremblay Breakdown of academic impact, for papers by Thomas J. Montine Breakdown of academic impact, for papers by Tim West Breakdown of academic impact, for papers by Ester Verdaguer Breakdown of academic impact, for papers by Liying Han Breakdown of academic impact, for papers by Philip B. Verghese Breakdown of academic impact, for papers by Inês Baldeiras
Rankless by CCL
2026